Nipro Corp
TSE:8086
Nipro Corp
TSE:8086
Price:
1 647
JPY
1.95%
Market Closed
Market Cap:
¥268.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Nipro Corp
TSE:8086
|
JP |
Multiples-Based Value
The
Multiples-Based Value for
Nipro Corp (8086)
under the Base Case is
4 117.82
JPY.
Compared with the current market price of 1 647 JPY, the stock appears
Undervalued by 60%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Multiples-Based Value
Base Case
4 117.82
JPY
Undervaluation 60%
Multiples Across Competitors
Competitors Multiples
Nipro Corp Competitors
Nipro Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| JP |
|
Nipro Corp
TSE:8086
|
268.6B JPY | 0.4 | 17.7 | 6.1 | 18.7 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.3T JPY | 10.2 | 37.2 | 26.9 | 32.3 | |
| CH |
|
Alcon AG
SIX:ALC
|
29.4B CHF | 3.6 | 38.5 | 14.8 | 28.8 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
35.9B USD | 0 | 0 | 0 | 0 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
99.8B DKK | 3.6 | 25.2 | 13.2 | 15.8 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.2B USD | 3 | 29.7 | 12.7 | 17.5 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
931.6B JPY | 7.2 | 52.7 | 25 | 33.9 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.8B USD | 1.1 | -16.2 | 17.2 | 55.7 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.3B GBP | 2.4 | 32.8 | 11.5 | 18 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
38.5B CNY | 8.5 | 23.3 | 20.9 | 20.9 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
38B CNY | 3.9 | 22.3 | 33.1 | 33.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
